BICO Group AB (publ) (OTCMKTS:CLLKF – Get Free Report) was the target of a significant decline in short interest during the month of April. As of April 30th, there was short interest totaling 658 shares, a decline of 98.2% from the April 15th total of 36,129 shares. Based on an average daily volume of 391 shares, the days-to-cover ratio is currently 1.7 days.
BICO Group AB (publ) Price Performance
OTCMKTS CLLKF traded up C$0.01 on Monday, hitting C$2.28. The firm has a 50-day simple moving average of C$2.09 and a two-hundred day simple moving average of C$2.12. BICO Group AB has a twelve month low of C$1.79 and a twelve month high of C$3.95.
BICO Group AB (publ) Company Profile
BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.
In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.
Featured Articles
- Five stocks we like better than BICO Group AB (publ)
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
